-
India and Japan sign 15 agreements including biotech, R&D, and science
biospectrumasia
September 19, 2017
India and Japan sign 15 agreements including biotech, R&D, and science There was an agreement to establish a joint exchange programme to identify and foster talented young scientists from both countries to collaborate in the field of theoretical biology.
-
Biotech hub outsources R&D to marketplace provider
europeanpharmaceuticalreview
September 08, 2017
LabCentral signs outsourced R&D provider Science Exchange, enabling access to more than 2,500 qualified scientific service providers
-
R&D leaders congregate at FDD Conclave 2017
expressbpd
June 19, 2017
Knowledge sharing galore at the inaugural edition of the FDD Conclave with several insightful discussions on key issues in drug formulation and delivery
-
Volition Opens New R&D Facility in Belgium
contractpharma
April 24, 2017
Significantly expands capacity for clinical trials and scientific team
-
Biotech standout Juno plans Bay Area office, hires ex-Genentech exec as R&D president
geekwire
April 18, 2017
Juno Therapeutics announced Monday that a former Genentech executive, Dr. Sunil Agarwal, has joined the company ...
-
Foresee Pharma Adds Two R&D Executives
contractpharma
April 18, 2017
Lee and Lau bring extensive medical, scientific and drug development expertise
-
Technology is key to improve R&D efficacy and cost effectiveness: Morgan Stanley report
financialexpress
April 17, 2017
It also highlights global tech companies’ investments to leverage opportunities arising through healthcare and technology convergence
-
Australian research receives A$125 mn funding boost
biospectrumasia
February 10, 2017
The National Health and Medical Research Council funding of A$125.3 million ($95.9 million) includes almost A$39 million to fight multiple types of cancer facing children and adults
-
Pharmaceutical R&D tax credit regulatory legislation: The need for clarity
pharmafile
January 23, 2017
Since their introduction in the UK in 2000, R&D tax credits have provided a significant boost to pharmaceutical and biotech firms that are almost constantly engaged in product innovation and development. Figures released by the UK government in September